Comparative efficacy of intraoperative radiotherapy and external boost irradiation in early-stage breast cancer: a systematic review and meta-analysis
- PMID: 37744215
- PMCID: PMC10512934
- DOI: 10.7717/peerj.15949
Comparative efficacy of intraoperative radiotherapy and external boost irradiation in early-stage breast cancer: a systematic review and meta-analysis
Abstract
External boost radiotherapy (EBRT) and intraoperative radiotherapy (IORT) are shown to be effective in patients with early-stage breast cancer. However, the difference between IORT and EBRT for patients' prognosis remains to be elucidated. The purpose of this meta-analysis is to investigate differences in local recurrence (LR), distant metastases, disease free survival (DFS), and overall survival (OS) between these two therapies. We searched the Cochrane Library, PubMed, Web of Science and Embase, from inception to Jan 10th, 2022. We used The Cochrane risk-of-bias assessment tool to assess the risk of bias of the included studies, and the STATA15.0 tool was used for the meta-analyses. Eight studies were ultimately included. Meta-analysis demonstrated that there was an inconsistent finding in the long-term risk of LR between the two radiotherapies, and there was no significant difference in short-term risk of LR, the metastasis rate, DFS, and OS IORT would be more convenient, less time-consuming, less costly, and more effective at reducing side effects and toxicity. However, these benefits must be balanced against the potential for increased risk of LR in the long term.
Keywords: Breast cancer; External irradiation therapy; Intraoperative radiation therapy; Meta-analysis; RCT.
©2023 Liu et al.
Conflict of interest statement
The authors declare there are no competing interests.
Figures
Similar articles
-
Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.Tumori. 2005 Jul-Aug;91(4):339-45. doi: 10.1177/030089160509100411. Tumori. 2005. PMID: 16277101
-
Cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for the adjuvant treatment of early breast cancer: A systematic review.Med J Islam Repub Iran. 2020 Dec 10;34:167. doi: 10.47176/mjiri.34.167. eCollection 2020. Med J Islam Repub Iran. 2020. PMID: 33816366 Free PMC article. Review.
-
Intraoperative radiotherapy (IORT) versus whole-breast external beam radiotherapy (EBRT) in early stage breast cancer: results from SEER database.Jpn J Radiol. 2020 Jan;38(1):85-92. doi: 10.1007/s11604-019-00891-7. Epub 2019 Nov 5. Jpn J Radiol. 2020. PMID: 31691091
-
Partial-breast irradiation versus whole-breast radiotherapy for early breast cancer: A systematic review and update meta-analysis.Brachytherapy. 2020 Jul-Aug;19(4):491-498. doi: 10.1016/j.brachy.2020.03.003. Epub 2020 Apr 24. Brachytherapy. 2020. PMID: 32340902
-
IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.Breast Cancer Res. 2021 Apr 13;23(1):46. doi: 10.1186/s13058-021-01424-9. Breast Cancer Res. 2021. PMID: 33849606 Free PMC article. Clinical Trial.
Cited by
-
Intraoperative radiotherapy might not serve as a standard therapy for retroperitoneal liposarcoma: insights from a population-based propensity score-matched study.Front Oncol. 2024 Oct 25;14:1431920. doi: 10.3389/fonc.2024.1431920. eCollection 2024. Front Oncol. 2024. PMID: 39525625 Free PMC article.
References
-
- Beddok A, Lahaye C, Calugaru V, De Marzi L, Fouillade C, Salvador S, Fontbonne JM, Favaudon V, Thariat J. A comprehensive analysis of the relationship between dose rate and biological effects in preclinical and clinical studies, from brachytherapy to flattening filter free radiation therapy and flash irradiation. International Journal of Radiation Oncology, Biology, Physics. 2022;113(5):985–995. doi: 10.1016/j.ijrobp.2022.02.009. - DOI - PubMed
-
- Ciabattoni A, Gregucci F, Fastner G, Cavuto S, Spera A, Drago S, Ziegler I, Mirri MA, Consorti R, Sedlmayer F. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study. Breast Cancer Research. 2021;23(1):46. doi: 10.1186/s13058-021-01424-9. - DOI - PMC - PubMed
-
- Hashemi S, Javadi S, Akbari ME, Mirzaei HR, Mahdavi SR. Outcomes of radical and boost dose of intraoperative radiotherapy with electron and low KV X-ray based on Islamic Republic intraoperative radiotherapy (IRIORT) consensus and the external beam radiotherapy in pure ductal carcinoma in situ (DCIS) in breast cancer patients. International Journal of Cancer Management. 2020;13(8):e105639. doi: 10.5812/ijcm.105639. - DOI
-
- Hashemi S, Javadi S, Akbari ME, Mirzaei H, Mahdavi SR. Comparison of IORT (Radical and Boost Dose) and EBRT in terms of disease-free survival and overall survival according to demographic, pathologic, and biological factors in patients with breast cancer. International Journal of Surgical Oncology. 2021;2021:2476527. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical